MedPath

Efficacy of Homoeopathic Potentized Medicine Carcinosinum in reduction of Serum Antibody levels in Hashimoto’s Thyroiditis

Phase 2
Conditions
Health Condition 1: E063- Autoimmune thyroiditis
Registration Number
CTRI/2023/11/059761
Lead Sponsor
Dr Rahitha K
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients from 18-60 years of age, All Genders.

2.Patients with Anti TPO above 34 IU/mL and/or Anti Thyroglobulin above 64 IU/mL.

3.Patients under Conventional Oral Hormone Replacement Therapy.

Exclusion Criteria

1.Cases with Malignant thyroid tumors.

2.Patients with other severe systemic illness like uncontrolled diabetes, Malignant Hypertension, Severe cardiac diseases, Malignancies.

3.Immuno-compromised patients- HIV/AIDS, TB.

4.Pregnant women and Lactating mothers.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath